Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: An analysis of the serological marker CA 19‐9
Steven A. Rogers, Daniel K. Podolsky – 1 February 1994 – Primary sclerosing cholangitis (PSC) predisposes to the development of cholangiocarcinoma, a usually fatal complication that is difficult to diagnose. Serum concentrations of CA 19‐9, a tumor‐associated antigen, are frequently increased in patients with only cholangiocarcinoma. The aim of this study was to assess the value of an increased serum CA 19‐9 level for the diagnosis of cholangiocarcinoma in patients with preexisting PSC.